Autocrine motility factor receptor promotes the malignancy of glioblastoma by regulating cell migration and invasion

CONCLUSION: This study suggests that AMFR could be used as a therapeutic strategy for the clinical treatment of glioblastoma.PMID:37703903 | DOI:10.1080/01616412.2023.2257463
Source: Neurological Research - Category: Neurology Authors: Source Type: research